Physician profile
Hannah Singleton
NPI 1689420507
$1,141.94
in general payments reported to CMS, 2019-2025
12 companies · $683 in 2025
The $683 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $459 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $151.14 | 2024 | Irrisept |
| Sanara Medtech INC. | $118.60 | 2024 | Celleraterx |
| Avita Medical Americas, LLC | $116.42 | 2024 | |
| Medtronic, INC. | $105.48 | 2025 | Transorb |
| Acera Surgical, INC. | $104.91 | 2025 | Restrata Wound Matrix |
| Conmed Corporation | $104.58 | 2025 | Airseal |
| Davol INC. | $104.47 | 2025 | Arista |
| Baxter Healthcare | $103.74 | 2025 | |
| Solventum Corporation | $92.31 | 2025 | V.A.C.Ulta, V.A.C.Instill, Prevena |
| Mimedx Group, INC. | $73.20 | 2024 | |
| Heron Therapeutics, INC. | $47.01 | 2025 | Zynrelef |
| Molnlycke Health Care US, LLC | $20.08 | 2025 | Avance, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.